The US FDA has accepted an amended investigational new drug application for the production and distribution of Radiopharm Theranostics' 68Ga-Trivehexin (RAD 301). …
US FDA gives green light for Trivehexin diagnostic Phase 1 pancreatic clinical trial
October 18, 2023 Australian Biotech
Latest Video
New Stories
-
From constitutional promise to creaking system - the PBS at 80
September 16, 2026 - - Latest News -
Young Australians badly misjudge when fertility starts to decline, new survey finds
September 16, 2026 - - Latest News -
A shorter name and bolder blue for Novo in global rebrand
September 15, 2026 - - Latest News -
New research points to a 'Doctor gap' holding back clinical trial participation in Australia
September 15, 2026 - - Latest News -
Persistent fatigue could be an overlooked sign of liver disease
September 15, 2026 - - Latest News -
Australia's 2026 flu vaccination season barely moves the needle on uptake
September 15, 2026 - - Latest News -
Noxopharm moves lupus skin therapy toward next human trial
September 14, 2026 - - Australian Biotech